| Market Cap | ₹6,952Cr |
| ROE | 23.91% |
| P/E Ratio(TTM) | 54.87 |
| EPS(TTM) | 7.96 |
| P/B Ratio | 13.01 |
| Dividend Yield | 1.60% |
| Industry P/E | 58.90 |
| Book Value | 33.57 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Parent Organisation | Thyrocare Technologies |
| Managing Director | Mr. Rahul Guha |
| Founded | 1996 |
| NSE Symbol | THYROCARE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 43.22 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 67.23 | ||
| Metropolis Healthcare | NA (0.00%) | 61.53 | ||
| Krsnaa Diagnostics | NA (0.00%) | 27.64 |